News
Highlights from the Latest PSMA & Beyond Conference
In late March, the third PSMA & Beyond Conference, co-hosted by the University of California, Los Angeles (UCLA) and the University of California, San Francisco (UCSF), with support from the Prostate Cancer Foundation (PCF), was held in Los Angeles. This year the conference focused on the current
Popular CT Scans Could Account for 5% of All Cancer Cases A Year
Computed tomography (CT) scans may account for 5% of all cancers annually, according to a new study out of UC San Francisco that cautions against overusing and overdosing CTs. The danger is greatest for infants, followed by children and adolescents. But adults also are at risk, since they are the
How Your Immune System Plays Matchmaker to Find and Kill HIV
What do the Tinder dating app and our immune system have in common? They are both committed to swiping candidates to screen for the perfect match. However, instead of love, our immune system is looking for signs of viruses in cells that should be destroyed, according to Sophia Miliotis, a UC San
Researchers Learn How a Drug Called Zotatifin Kills Cancer Cells
Swirling inside every cell are millions of microscopic messages called messenger RNAs (mRNAs). The messages are the genetic blueprints for proteins, which determine the behavior and health of the cell. All mRNAs are packaged to ensure they’re only used at the right place and time – imagine notes
More Than Treatment: Bridging Gaps in Pediatric Cancer Care
Pediatric cancer treatment is one of the greatest successes of modern medicine, with around 80% of diagnosed children living as long-term survivors. But many children—especially from underserved areas—don’t fully benefit from these advances due to barriers to accessing life-saving therapies and
How to Build Bold Thinking to Foster Scientific Breakthroughs
Collectively, neuropsychiatric and neurodegenerative diseases are leading causes of illness, disability and premature death worldwide. And while they are categorized separately, they have much in common. Similarly, Martin Kampmann, PhD, who studies neurodegenerative diseases, and Anna Victoria